Growth Metrics

BioLineRx (BLRX) Operating Income Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.69%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -347.04%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 80.62%
7 Evaxion A 64.16 Bn 64.14 Bn - 1.27%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,386.07%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 23.50%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 23.50%
Sep 30, 2025 59.03%
Jun 30, 2025 60.11%
Mar 31, 2025 50.41%
Dec 31, 2024 76.16%
Sep 30, 2024 56.41%
Jun 30, 2024 41.78%
Mar 31, 2024 45.55%
Dec 31, 2023 -121.08%
Sep 30, 2023 -74.58%
Jun 30, 2023 -30.43%
Mar 31, 2023 -45.68%
Dec 31, 2022 -27.28%
Sep 30, 2022 -13.85%
Jun 30, 2022 -16.72%
Mar 31, 2022 -11.56%
Dec 31, 2021 -12.36%
Sep 30, 2021 -33.73%
Jun 30, 2021 -17.01%
Mar 31, 2021 20.34%
Dec 31, 2020 37.62%
Sep 30, 2020 30.02%
Jun 30, 2020 14.07%
Mar 31, 2020 -22.62%
Dec 31, 2019 -33.76%
Sep 30, 2019 -6.94%
Jun 30, 2019 -13.10%
Mar 31, 2019 15.85%
Dec 31, 2018 8.47%
Sep 30, 2018 11.97%
Jun 30, 2018 -10.26%
Mar 31, 2018 -25.05%
Dec 31, 2017 -75.36%
Sep 30, 2017 -57.24%
Jun 30, 2017 -34.35%
Mar 31, 2017 -40.39%
Dec 31, 2016 -6.93%
Sep 30, 2016 -24.56%
Jun 30, 2016 7.20%
Mar 31, 2016 12.73%
Dec 31, 2015 21.11%
Sep 30, 2015 11.50%
Jun 30, 2015 -6.52%
Mar 31, 2015 -6.16%
Dec 31, 2014 -127.34%
Sep 30, 2014 -24.31%
Jun 30, 2014 15.55%
Mar 31, 2014 37.35%